IL6R and prostate carcinoma: Figure 1 shows that among prostate cancer cases there was a shorter waiting time-to-onset in IL6R Asp358Ala C-allele carriers (P = 0.026) and in IGF1R+3174 AA homozygous (P = 0.002).